Search or add a thesis

Advanced Search (Beta)
Home > Political History of Pakistan and Imposition of Martial 1947-2007

Political History of Pakistan and Imposition of Martial 1947-2007

Thesis Info

Author

Mian Shah Hussain

Department

Pakistan Study Centre

Program

MA

Institute

University of Peshawar

Institute Type

Public

City

Peshawar

Country

Pakistan

Degree Starting Year

2005

Degree End Year

2007

Subject

Pak Studies

Language

English

Added

2021-02-17 19:49:13

Modified

2023-02-17 21:08:06

ARI ID

1676710794245

Similar


Loading...
Loading...

Similar Books

Loading...

Similar Chapters

Loading...

Similar News

Loading...

Similar Articles

Loading...

Similar Article Headings

Loading...

مجھے کتنی سہولت ہے

مجھے کتنی سہولت ہے۔۔۔ازہر ندیم

 

مجھے جب زندگی کے حسن کا ادراک کرنا ہو

مجھے جب آسماں کی وسعتوں سے بات کرنی ہو

مجھے پھولوں ستاروں سے کوٸ منظر سجانا ہو

مجھے خوشبو سے مہکے موسموں کو گھر بلانا ہو

مجھے رنگوں کی دلکش وادیوں کی سیر کرنی ہو

مجھے آواز کے جادو میں جب بھی ڈوب جانا ہو

مجھے کتنی سہولت ہے

میں ان پھیلی ہواٶں میں بس اک پیغام لکھتا ہوں

میں ان خالی فضاٶں میں تمہارا نام لکھتا ہوں

مجھے ہر سو جمالِ خواب کی برسات ملتی ہے

تمہاری یاد سے مجھ کو ، یہ کاٸنات ملتی ہے

مجھے کتنی سہولت ہے

Quran and War Media: Towards a More Constructed Approach to Conflict Reporting

This study critiques the existing journalistic practices for being deficit in ensuring constructive reporting of wars and conflicts. Though the available academic scholarship developed at the Westernized settings offer a number of alternatives, however due to the peculiar socio-cultural conditions in Pakistan and rest of the Islamic societies, these approaches are not very practical. The authors of the present study propose a more contextual and an Islamic oriented model to facilitate journalists in Pakistan to produce more effective and constructive reporting of conflicts. We believe the model inspired by the Islamic injunctions would only ensure a more professional and practical approach for conflict reporting but it would also facilitate peaceful resolution of conflicts which at present are escalated by the existing practices.

Identification and Modeling of Regulatory Networks and Development of Anti-Cancer Drug-Conjugated Nanoparticles for Breast Cancer Therapy

Breast cancer is the second leading cause of cancer-related mortalities among females worldwide. It is genetically heterogeneous disease caused by various environmental and genetic factors. Abnormal expression of various genes/proteins such as chemokine C-X-C motif (receptor 4), insulin like growth factor-1 receptor and estrogen growth factor receptor and their associated biological regulatory networks are linked with breast cancer. In this study, the crosstalk interaction between these genes/proteins and their associated signaling networks involved in breast cancer metastasis were studied by using both in-silico (qualitative modeling, hybrid PetriNet modeling, pharmacophore modeling and virtual screening) and in-vitro approaches (genotyping, cell viability assay, quantitative real time polymerase chain reaction and western blotting). The association of rs1801157 single nucleotide polymorphism, located within the C-X-C motif ligand 12 (CXCL12) gene, with the development of breast cancer was assessed. The results of genotyping showed the significant prevalence of genotype GG (p<0.05) with a number of variables including patient’s age, weight, lymph nodes status, hormonal imbalances (ER and PR) and family history using multivariable logistic regression among Pakistani breast cancer patients as compared to AA genotype. Our in-silico results suggested that rs1801157 single nucleotide polymorphism identified in CXCL12 gene has crosstalk link with insulin like growth factor-1 receptor (IGF-1R) and epidermal growth factor receptor (EGFR) signaling and is an important factor in predicting the outcomes of breast cancer therapy, which can also result in multidrug resistance due to induction of insulin like growth factor-1. Furthermore, to address the problem of multidrug resistance in breast cancer cells, an effective and non-toxic biologically synthesized silver nanoparticles (drug delivery vehicles) were conjugated with anti-cancer inhibitors such as fulvestrant and gefitinib to inhibit the activity of multiple genes and proteins such as estrogen growth factor receptor, C-X-C motif (ligand 12), phosphoinositide 3 kinase, insulin receptor substrate-1, insulin like growth factor-1 receptor, PDZ domain containing 1 and estrogen receptor-α to treat breast cancer cells. In conclusion, for a multifactorial disease like breast cancer, more than one therapeutic targets should be inhibited with an effective drug delivery vehicle to induce apoptosis in cancer cells.